Literature DB >> 10971808

Vasopressin and oxytocin neurones of hypothalamic supraoptic and paraventricular nuclei co-express mRNA for Type-1 and Type-2 corticotropin-releasing hormone receptors.

H Arima1, G Aguilera.   

Abstract

The presence of corticotropin-releasing hormone (CRH) receptors type-1 (CRHR-1) and type-2 (CRHR-2alpha) in the hypothalamic supraoptic (SON) and paraventricular (PVN) nuclei, and the effects of i.c.v. injection of CRH and urocortin on arginine vasopressin (AVP) and oxytocin release, have suggested that CRH ligands have a role in osmoregulation. In this study, double labelling in situ hybridization using 35S-labelled CRHR-1 or CRHR-2alpha and digoxigenin-labelled AVP, oxytocin or CRH riboprobes was employed to examine the localization of CRHR-1 or CRHR-2alpha mRNA in the SON and PVN of control and osmotically stimulated rats. Rats received an i.p. hypertonic saline (1.5 M) injection or isotonic saline injection (controls), or 2% NaCl intake (salt loading) or tap water (controls) for 12 days. While CRHR-1 mRNA was undetectable in the SON and PVN in control rats, its expression was increased markedly at 4 h after i.p. hypertonic saline injection or after 12 days salt loading. Of the cells labelled with digoxigenin-AVP, 53% in the SON and 90% in the PVN coexpressed CRHR-1 mRNA after i.p. hypertonic saline injection. In oxytocinergic neurones, 73% in the SON and 91% in the PVN showed CRHR-1 autoradiographic grains higher than background levels after i.p. hypertonic saline injection. In addition, i.p. hypertonic saline induced CRHR-1 mRNA expression in digoxigenin-CRH stained cells in the parvocellular PVN. CRHR-2alpha transcripts were present in both the SON and PVN under basal conditions, and salt loading, but not acute i.p. hypertonic saline injection, further stimulated this expression. Double labelling in situ hybridization showed colocalization of CRHR-2alpha mRNA with AVP and oxytocin mRNA in the SON. These studies support a role for CRH and urocortin regulating the hypothalamo-neurohypophyseal system, and suggest a direct action of the peptides in the magnocellular neurones.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971808     DOI: 10.1046/j.1365-2826.2000.00528.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  15 in total

1.  Quantifying nonlinear interactions within the hypothalamo-pituitary-adrenal axis in the conscious horse.

Authors:  Daniel M Keenan; Sue Alexander; Clifford Irvine; Johannes D Veldhuis
Journal:  Endocrinology       Date:  2008-11-20       Impact factor: 4.736

2.  Corticotropin-releasing factor receptor 2-deficiency eliminates social behaviour deficits and vulnerability induced by cocaine.

Authors:  Nadège Morisot; Romain Monier; Catherine Le Moine; Mark J Millan; Angelo Contarino
Journal:  Br J Pharmacol       Date:  2018-03-13       Impact factor: 8.739

Review 3.  Response of substances co-expressed in hypothalamic magnocellular neurons to osmotic challenges in normal and Brattleboro rats.

Authors:  Jana Bundzikova; Zdeno Pirnik; Dora Zelena; Jens D Mikkelsen; Alexander Kiss
Journal:  Cell Mol Neurobiol       Date:  2008-09-05       Impact factor: 5.046

4.  Mice transgenically overexpressing sulfonylurea receptor 1 in forebrain resist seizure induction and excitotoxic neuron death.

Authors:  C Hernández-Sánchez; A S Basile; I Fedorova; H Arima; B Stannard; A M Fernandez; Y Ito; D LeRoith
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

5.  Neuroanatomical evidence for reciprocal regulation of the corticotrophin-releasing factor and oxytocin systems in the hypothalamus and the bed nucleus of the stria terminalis of the rat: Implications for balancing stress and affect.

Authors:  Joanna Dabrowska; Rimi Hazra; Todd H Ahern; Ji-Dong Guo; Alexander J McDonald; Franco Mascagni; Jay F Muller; Larry J Young; Donald G Rainnie
Journal:  Psychoneuroendocrinology       Date:  2011-04-09       Impact factor: 4.905

6.  Fos proteins are not prerequisite for osmotic induction of vasopressin transcription in supraoptic nucleus of rats.

Authors:  Hiroshi Arima; Ruben Baler; Greti Aguilera
Journal:  Neurosci Lett       Date:  2010-09-17       Impact factor: 3.046

Review 7.  Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs.

Authors:  Eva M Fekete; Eric P Zorrilla
Journal:  Front Neuroendocrinol       Date:  2006-11-02       Impact factor: 8.606

8.  Urocortin II increases spontaneous parental behavior in prairie voles (Microtus ochrogaster).

Authors:  Peter A Samuel; Caroline M Hostetler; Karen L Bales
Journal:  Behav Brain Res       Date:  2007-08-19       Impact factor: 3.332

9.  Neural circuitry underlying the central hypertensive action of nesfatin-1: melanocortins, corticotropin-releasing hormone, and oxytocin.

Authors:  Gina L C Yosten; Willis K Samson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-03-05       Impact factor: 3.619

Review 10.  Stress, sex, and addiction: potential roles of corticotropin-releasing factor, oxytocin, and arginine-vasopressin.

Authors:  Verónica Bisagno; Jean Lud Cadet
Journal:  Behav Pharmacol       Date:  2014-09       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.